(Information sent by the signatory company)
– Research topic: new strategies to involve neurophils in solid tumors –
OSAKA, Japan, Jan. 9, 2024/PRNewswire/ — Ono Pharmaceutical Co., Ltd. (Osaka, Japan) reported that it has entered into a new collaboration with BioMed X (Heidelberg, Germany) on cancer immunotherapies and has been inviting to researchers interested in this research project through BioMed X.
For more information, please see the following BioMed X press release and application guidelines for the research project:
BioMed X Press Release December 19, 2023: BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
Application Guidelines for Research Project: Call for Application
(Application Summary) For more information, see the link above. Research topic: New strategies to involve neutrophils in solid tumors Project duration: 3 – 5 years Application deadline: February 18, 2024
Logo – https://mma.prnewswire.com/media/1636289/ONO_PHARMA_USA_Logo.jpg
View original content: https://www.prnewswire.com/es/comunicados-de-prensa/convocatoria-para-investigadores-para-proyecto-de-investigacion-conjunto-entre-ono-pharmaceutical-y-biomed-x-302029869.html
